For localized information and support, would you like to switch to your country-specific website for {0}?
VENTANA® Kappa and Lambda Dual ISH mRNA Probe Cocktail
An ultra-sensitive Kappa and Lambda multiplex ISH assay to aid in the diagnosis of all B-cell lymphomas and plasma cell neoplasms
The VENTANA® Kappa and Lambda Dual ISH mRNA Probe Cocktail is a dual-color assay that enables clonality assessment in all B-cell lymphoma subtypes and plasma cell neoplasms. An innovative assay that offers unparalleled sensitivity and specificity for assessing Kappa and Lambda light chains across all B-cell lymphoma subtypes. Unlike current IHC, single ISH, and flow cytometry methods, this innovative assay provides a superior diagnostic option B-cell lymphoma diagnosis.1
Roche offers an extensive Heme portfolio with more than 60 ready-to-use markers that are optimised for use on our BenchMark instruments.5 With the launch of VENTANA Kappa and Lambda Dual ISH, Roche demonstrates its commitment to invest in innovative technology that advances science in the hematopathology space and improves patient care.
Related products
How Roche is contributing to advancing the treatment of lymphomas
For more than 20 years, Roche has been striving to make a difference for people with lymphoma by investing in developing innovative therapies that meet the unique needs of every patient.
References
- F. Hoffmann La Roche Ltd. VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail Method Sheet. (v C). 2025.
- Rimsza LM, et al. Kappa and Lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas. Diagn Pathol. 2014;9:144.
- F. Hoffmann La Roche Ltd. Pathology Lab Catalog. [Internet; cited 2024 Apr 15]. Available from: https://diagnostics.roche.com/global/en/products/product category/anatomical pathology.html
- Sen A, Gupta D, Jagani R. Rapid in situ hybridization and immunohistochemistry: a pilot comparative study of two rapid diagnostic techniques for establishing monoclonality in plasma cell dyscrasias. Med J Armed Forces India. 2020 Jan;76(1):103-108.
- F. Hoffmann La Roche Ltd. IHC Menu. 2025.